agilon health appoints Diana L. McKenzie to Board of Directors

agilon health, inc.

Appointed as Class II director effective February 17, 2023, term expiring at 2023 annual meeting.
Will serve on Audit Committee and Compensation and Human Capital Committee.
Former CIO at Workday (2016-2019), Amgen (2004-2016), and Eli Lilly (1987-2004).
No related party transactions; compensation per existing non-employee director program.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Diana L. McKenzie

Class II director

AGL · agilon health, inc.

Effective: 2023-02-17
Filed: February 22, 2023, 6:59 PM ET

Effective February 17, 2023, to fill a vacancy on the Board of Directors, Diana L. McKenzie was appointed to the Board as a Class II director in accordance with the Amended and Restated Certificate of Incorporation of agilon health, inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Diana L. McKenzie was appointed as Class II director at agilon health, inc..

Action: appointed
Role: Class II director

Exact text from the filing

Effective February 17, 2023, to fill a vacancy on the Board of Directors, Diana L. McKenzie was appointed to the Board as a Class II director in accordance with the Amended and Restated Certificate of Incorporation of agilon health, inc.

View on SEC.gov

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-003586

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.